Ambiq Micro Files S-1 for $152.3M - $175.2M Common Stock Offering at $90.48/Share
AMBQ has more than doubled off its 52-week low of $22.12 on elevated volume (3.6× avg).
Summary
Ambiq Micro is registering a public offering of up to 2.07 million shares of common stock, aiming to raise up to $175.2 million at an assumed price of $90.48 per share, which is near its 52-week high.
Key Events · Financing and Capital Events · AMBQ
-
Public Offering Initiated
Ambiq Micro has filed an S-1 registration statement for a public offering of 1.8 million shares of common stock, with an option for underwriters to purchase an additional 270,000 shares.
-
Significant Capital Raise
The offering is expected to generate net proceeds of approximately $152.3 million, potentially increasing to $175.2 million if the underwriters' option is fully exercised.
-
Strong Offering Price
Shares are offered at an assumed price of $90.48 per share, which is near the company's 52-week high of $91.61 and significantly higher than the $31.00/share from a previous follow-on offering in January 2026.
-
Share Dilution
The offering represents a potential dilution of 8.43% to 9.69% to existing shareholders, with new investors facing an immediate dilution of $74.25 per share.
Analysis · AMBQ · Manufacturing
Ambiq Micro has filed an S-1 registration statement for a public offering of 1.8 million shares of common stock, with an option for underwriters to purchase an additional 270,000 shares. This offering aims to raise estimated net proceeds of $152.3 million, potentially reaching $175.2 million if the option is fully exercised. The assumed offering price of $90.48 per share is near the company's 52-week high and represents a significant premium over its $31.00/share follow-on offering in January 2026. While the capital raise is substantial, representing 7.87% to 9.06% of the current market cap and causing 8.43% to 9.69% dilution to existing shareholders, it provides crucial funding for general corporate purposes, including R&D and potential acquisitions. This capital infusion follows strong Q1 2026 financial results, but also a period of notable insider selling, presenting a mixed signal to the market.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 36.9% of the 1029 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMBQ was trading at $92.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $22.12 to $91.61. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.